167 related articles for article (PubMed ID: 19416087)
21. Monoclonal antibodies to mouse butyrylcholinesterase.
Mrvova K; Obzerova L; Girard E; Krejci E; Hrabovska A
Chem Biol Interact; 2013 Mar; 203(1):348-53. PubMed ID: 23099085
[TBL] [Abstract][Full Text] [Related]
22. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
[TBL] [Abstract][Full Text] [Related]
23. A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India.
Manoharan I; Boopathy R; Darvesh S; Lockridge O
Clin Chim Acta; 2007 Mar; 378(1-2):128-35. PubMed ID: 17182021
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
[TBL] [Abstract][Full Text] [Related]
25. Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors.
Lockridge O; Norgren RB; Johnson RC; Blake TA
Chem Res Toxicol; 2016 Sep; 29(9):1381-92. PubMed ID: 27551784
[TBL] [Abstract][Full Text] [Related]
26. The butyrylcholinesterase knockout mouse is obese on a high-fat diet.
Li B; Duysen EG; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):88-91. PubMed ID: 18452903
[TBL] [Abstract][Full Text] [Related]
27. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
[TBL] [Abstract][Full Text] [Related]
28. Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease.
Darvesh S
Curr Alzheimer Res; 2016; 13(10):1173-7. PubMed ID: 27040140
[TBL] [Abstract][Full Text] [Related]
29. Bone status of adult female butyrylcholinesterase gene-deficient mice.
Haupt M; Kauschke V; Sender J; Kampschulte M; Kovtun A; Dürselen L; Heiss C; Lips KS
Int Immunopharmacol; 2015 Nov; 29(1):208-14. PubMed ID: 26138460
[TBL] [Abstract][Full Text] [Related]
30. Differential sensitivity of plasma carboxylesterase-null mice to parathion, chlorpyrifos and chlorpyrifos oxon, but not to diazinon, dichlorvos, diisopropylfluorophosphate, cresyl saligenin phosphate, cyclosarin thiocholine, tabun thiocholine, and carbofuran.
Duysen EG; Cashman JR; Schopfer LM; Nachon F; Masson P; Lockridge O
Chem Biol Interact; 2012 Feb; 195(3):189-98. PubMed ID: 22209767
[TBL] [Abstract][Full Text] [Related]
31. Effects of parathion on acetylcholinesterase, butyrylcholinesterase, and carboxylesterase in three-spined stickleback (Gasterosteus aculeatus) following short-term exposure.
Wogram J; Sturm A; Segner H; Liess M
Environ Toxicol Chem; 2001 Jul; 20(7):1528-31. PubMed ID: 11434294
[TBL] [Abstract][Full Text] [Related]
32. Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model.
Reid GA; Darvesh S
Neuroscience; 2015 Jul; 298():424-35. PubMed ID: 25931333
[TBL] [Abstract][Full Text] [Related]
33. DNA sequence of butyrylcholinesterase from the rat: expression of the protein and characterization of the properties of rat butyrylcholinesterase.
Boeck AT; Schopfer LM; Lockridge O
Biochem Pharmacol; 2002 Jun; 63(12):2101-10. PubMed ID: 12110369
[TBL] [Abstract][Full Text] [Related]
34. Butyrylcholinesterase: A Multifaceted Pharmacological Target and Tool.
Ha ZY; Mathew S; Yeong KY
Curr Protein Pept Sci; 2020; 21(1):99-109. PubMed ID: 31702488
[TBL] [Abstract][Full Text] [Related]
35. Multifarious Functions of Butyrylcholinesterase in Neuroblastoma: Impact of BCHE Deletion on the Neuroblastoma Growth In Vitro and In Vivo.
Baranowska-Kortylewicz J; Kortylewicz ZP; McIntyre EM; Sharp JG; Coulter DW
J Pediatr Hematol Oncol; 2022 Aug; 44(6):293-304. PubMed ID: 34486544
[TBL] [Abstract][Full Text] [Related]
36. Whole body and tissue imaging of the butyrylcholinesterase knockout mouse injected with near infrared dye labeled butyrylcholinesterase.
Duysen EG; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):119-24. PubMed ID: 18486120
[TBL] [Abstract][Full Text] [Related]
37. [Activity of esterases and effect of genetic polymorphism in workers exposed to organophosphorus pesticides].
Kuang XY; Zhou ZJ; Ma XX; Yao F; Wu QE; Chen B
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jun; 24(6):333-6. PubMed ID: 16824336
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-transduced human butyrylcholinesterase in mouse blood functions as a bioscavenger of chemical warfare nerve agents.
Chilukuri N; Duysen EG; Parikh K; diTargiani R; Doctor BP; Lockridge O; Saxena A
Mol Pharmacol; 2009 Sep; 76(3):612-7. PubMed ID: 19542320
[TBL] [Abstract][Full Text] [Related]
39. Intrathecal delivery of fluorescent labeled butyrylcholinesterase to the brains of butyrylcholinesterase knock-out mice: visualization and quantification of enzyme distribution in the brain.
Johnson ND; Duysen EG; Lockridge O
Neurotoxicology; 2009 May; 30(3):386-92. PubMed ID: 19442823
[TBL] [Abstract][Full Text] [Related]
40. [Prolonged neuromuscular block in a patient with butyrylcholinesterase deficiency].
Mabboux I; Hary B; Courcelle S; Ceppa F; Delacour H
Arch Pediatr; 2016 May; 23(5):497-500. PubMed ID: 27017361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
